The Apothecary Shops receives distribution rights for Eylea
PHOENIX — The wholesale arm of specialty pharmacy The Apothecary Shops has received distribution rights to a drug for treating age-related macular degeneration, the company said Thursday.
Apothecary Shops Wholesale has begun distributing Regeneron Pharmaceuticals' Eylea (aflibercept) to physicians and patients. The drug is used to treat neovascular or "wet" AMD. The "wet" form usually leads to more serious vision loss.
"With over 17 years of ophthalmology practice experience, The Apothecary Shops are among the finest specialty pharmacies in the nation, particularly with regard to ophthalmological medications," Apothecary Shops national director of ophthalmology Jim Rehovsky said. "And to better serve our customers who are prescribed the Eylea injection, we have the ability to work directly with the administering physician and the insurance provider to give our customers broader access options."
Last week, Diplomat Specialty Pharmaceuticals also announced that it received distribution rights for the drug.